Wall Street Access Asset Management, LLC Amicus Therapeutics, Inc. Transaction History

Wall Street Access Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $341,090 - $884,609	-37,075 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $44,114 - $81,514	-3,275 Reduced 8.12%	37,075 $856,000
Q2 2020 Nov 02, 2021	BUY	$8.86 - $15.69 $48,508 - $85,902	5,475 Added 15.7%	40,350 $608,000
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $89,007 - $149,823	13,425 Added 62.59%	34,875 $322,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $160,446 - $230,587	21,450 New	21,450 $208,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.74B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.